China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
The multilateral trading system, birthed on October 30, 1947, was unceremoniously knifed and left for dead by President Biden’s signing of the Inflation Reduction Act.
A look at what some senior executives are saying this earnings season about the dollar’s misalignment with the major currencies of the world.
CPA economists Jeff Ferry and Amanda Mayoral explain the continued deterioration of market share for domestic producers versus imports.
CPA tax policy director, David Morse, explains why mostly-domestic companies with over a billion in profits might get a more even playing field with rivals who use profit shifting, offshoring, to pay less taxes.
In a surprise development last night, Senate Majority Leader Chuck Schumer (D, N.Y.) and Senator Joe Manchin (D, W.Va.), with support from President Biden, announced
Yesterday, Senator Majority Leader Chuck Schumer (D-NY) and Senator Joe Manchin (D-WV) announced that they reached a deal on a reconciliation package that would change
CPA chief economist Jeff Ferry says the CHIPS Act is needed to counter China’s rise in the semiconductor space, and that the R&D component of the bill needs to include guardrails so American academia isn’t beta-testing and researching new chips in partnership with Chinese universities and companies.
U.S. solar industry getting little to no help from the Biden administration.
By Charles Benoit, CPA Trade Counsel Last month, President Biden stunned the trade community around the world when he announced a two-year legal immunity from